Showing results (51-60 of 79) with videos related to
Sort By:
Pageof 8
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|May 24, 2014
Short-term effects of oral administration of Pistacia lentiscus oil on tissue-specific toxicity and drug metabolizing enzymes in miceSamir Attoub, Sherif M Karam, Abderrahim Nemmar, et al.Plos One|July 23, 2013
Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide productionYusra Al Dhaheri, Samir Attoub, Kholoud Arafat, et al.Annals of the New York Academy of Sciences|October 8, 2008
Captopril as a potential inhibitor of lung tumor growth and metastasisSamir Attoub, Anne Marie Gaben, Suhail Al-Salam, et al.European Biophysics Journal : EBJ|February 12, 2011
Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYaMohammed Akhter Hossain, Laure Guilhaudis, Agnes Sonnevend, et al.Fundamental & Clinical Pharmacology|July 14, 2012
Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivoSamir Attoub, Olivier Sperandio, Haider Raza, et al.Plos One|January 12, 2013
Frondoside a suppressive effects on lung cancer survival, tumor growth, angiogenesis, invasion, and metastasisSamir Attoub, Kholoud Arafat, An Gélaude, et al.Journal of Natural Products|November 26, 2015
Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced ToxicitiesGiorgia Manzo, Mariano Andrea Scorciapino, Dinesh Srinivasan, et al.European Journal of Pharmacology|July 12, 2011
Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenograftsNadia Al Marzouqi, Rabah Iratni, Abderrahim Nemmar, et al.Cancer Research|September 5, 2002
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapySamir Attoub, Christine Rivat, Sylvie Rodrigues, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 6, 2003
Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasionChristine Rivat, Nathalie Le Floch, Michèle Sabbah, et al.Pageof 8